LIBERATE Intervention for Type 2 Diabetes

St. Joseph's Family Medical and Dental Centre, London, Canada

LIBERATEN/ARecruitingLed by Sonja M Reichert, MDResearch Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Naïve to Flash glucose monitors BUT interested in using this technology

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up6 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trialwill test a 6-month program, with bi-weekly group classes and weekly communication, to help people with diabetes manage their health through nutrition and exercise.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You have never used a Flash glucose monitor before but you are interested in trying this technology.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HbA1c from Baseline

Secondary outcome measures

Change in rapid insulin use from Baseline

Change in total daily basal insulin use from baseline

Other outcome measures

Anthropometric: Change in Height from baseline

Anthropometric: Change in Waist circumference from baseline

Anthropometric: Change in Weight from baseline

+19 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: LIBERATE InterventionExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a site

Who is running the clinical trial?

Abbott Diabetes CareIndustry Sponsor

61 Previous Clinical Trials

24,393 Total Patients Enrolled

Western University, CanadaLead Sponsor

218 Previous Clinical Trials

39,598 Total Patients Enrolled

Sonja M Reichert, MDPrincipal Investigator

Western University

Media Library

LIBERATE Clinical Trial Eligibility Overview. Trial Name: NCT05261906 — N/A

Type 2 Diabetes Research Study Groups: LIBERATE Intervention

Type 2 Diabetes Clinical Trial 2023: LIBERATE Highlights & Side Effects. Trial Name: NCT05261906 — N/A

LIBERATE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05261906 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study still recruiting participants?

"Affirmative. Clinicaltrials.gov's records inform us that the enrollment window for this clinical trial is open, and it was first posted on September 26th 2022 before being updated on October 7th 2022. 184 participants are required from 1 site to complete the study."

Answered by AI

What is the maximum number of enrollees for this scientific investigation?

"Affirmative. Data provided on clinicaltrials.gov says that this research project is currently requiring participants, with the first posting occuring on September 26th 2022 and last amendment happening October 7th 2022. In total, 184 people are being welcomed at 1 site for participation in this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exercise Study

Sonja Reichert 2022. "The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exercise Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05261906.

All > Diabetes Type 2